Peer2Me: A Peer Supported Program for Adolescent and Young Adult Cancer Patients
NCT ID: NCT05336318
Last Updated: 2024-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
180 participants
INTERVENTIONAL
2021-01-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Peer Support on Quality of Life in Recently Diagnosed Breast Cancer Patients
NCT03394742
Patient Ambassador Support in Newly Diagnosed Patients With Acute Leukemia During Treatment
NCT03493906
Peer Mentoring in Promoting Follow-up Care Self-Management in Younger Childhood Cancer Survivors
NCT02699996
Stepped Care - Optimising Psycho-oncological Care Provision by Structured Screening and Diagnosis
NCT01859429
Electronic Psycho-oncological Adaptive Screening Program
NCT04749056
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A total of 180 acutely ill adolescent and young cancer patients (AYA) between the ages of 18 and 39 will be included in the study (intervention and control group). Again, young former cancer patients who have completed treatment will act as mentors and accompany acutely ill AYAs in the period after diagnosis for a period of three months. Prior to their assignment, the mentors take part in a training course, which includes the teaching of suitable conversation techniques, core topics in dealing with the cancer and advice on further care structures. Patients in the control group receive 30 minutes of standardized counseling regarding psychosocial care needs, including appropriate informational materials, during AYA consultation hours at both clinic sites. The study includes three measurement time points: t1: before the intervention; t2: after the end of the intervention; t3: 3 months after the end of the intervention. At all time points, participants will be surveyed using standardized questionnaires. With the help of these data and a comprehensive statistical analysis, the investigators want to make valid statements regarding the effects of peer mentoring on changes in psychological well-being as well as on social support and coping with illness.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Peer support
patients were supported by a mentor
Control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peer support
patients were supported by a mentor
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* completion of acute treatment at least 2 years ago (mentors)
* curative prognosis
* Native language German or fluent German speaker
* first cancer diagnosis in the last 6 months (mentees, all tumor entities)
* curative prognosis
Exclusion Criteria
* palliative treatment approach
18 Years
39 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitätsklinikum Hamburg-Eppendorf
OTHER
University of Leipzig
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anja Mehnert
Prof. Anja Mehnert-Theuerkauf
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diana Richter, PhD.
Role: PRINCIPAL_INVESTIGATOR
Universitätsklinikum Leipzig
Corinna Bergelt, Prof.
Role: PRINCIPAL_INVESTIGATOR
University Medicine Greifswald, Institute for Medical Psychology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center Leipzig
Leipzig, Saxony, Germany
University Medical Center Hamburg-Eppendorf, Department of Medical Psychology
Hamburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Anja Mehnert, PhD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Brock H, Dwinger S, Friedrich M, Sender A, Geue K, Mehnert-Theuerkauf A, Bergelt C, Richter D. Peer2Me - impact of peer support on self-efficacy in young adult cancer survivors (YA-CS): findings from a comprehensive cohort design. BMC Cancer. 2025 May 26;25(1):943. doi: 10.1186/s12885-025-14323-5.
Brock H, Dwinger S, Bergelt C, Sender A, Geue K, Mehnert-Theuerkauf A, Richter D. Peer2Me - evaluation of a peer supported program for adolescent and young adult (AYA) cancer patients: study protocol of a randomised trial using a comprehensive cohort design. BMC Cancer. 2024 Jul 2;24(1):788. doi: 10.1186/s12885-024-12547-5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DKH-70114047
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.